BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Nastro F, Fabbrocini G, di Vico F, Marasca C. Small vessel vasculitis related to varicella-zoster virus after Pfizer-BioNTech COVID-19 vaccine. J Eur Acad Dermatol Venereol 2021. [PMID: 34310759 DOI: 10.1111/jdv.17550] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 5.0] [Reference Citation Analysis]
Number Citing Articles
1 Salehi S, Sadeghi S, Kalantari Y, Goodarzi A. A Systematic Review of Histopathologic Surveys on Mucocutaneous Biopsies in Patients Developed COVID-19 Vaccine-Related Dermatologic Manifestations. Am J Dermatopathol 2023;45:1-27. [PMID: 36484603 DOI: 10.1097/DAD.0000000000002320] [Reference Citation Analysis]
2 Mohseni Afshar Z, Sharma A, Babazadeh A, Alizadeh-khatir A, Sio TT, Taghizadeh Moghadam MA, Tavakolli Pirzaman A, Mojadad A, Hosseinzadeh R, Barary M, Ebrahimpour S. A review of the potential neurological adverse events of COVID-19 vaccines. Acta Neurol Belg 2022. [DOI: 10.1007/s13760-022-02137-2] [Reference Citation Analysis]
3 Yamamoto M, Kase M, Sano H, Kamijima R, Sano S. Persistent varicella zoster virus infection following mRNA COVID ‐19 vaccination was associated with the presence of encoded spike protein in the lesion. J Cutaneous Imm & Allergy 2022. [DOI: 10.1002/cia2.12278] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
4 Maronese CA, Zelin E, Avallone G, Moltrasio C, Romagnuolo M, Ribero S, Quaglino P, Marzano AV. Cutaneous vasculitis and vasculopathy in the era of COVID-19 pandemic. Front Med 2022;9. [DOI: 10.3389/fmed.2022.996288] [Reference Citation Analysis]
5 Martinez-reviejo R, Tejada S, Adebanjo GA, Chello C, Machado MC, Parisella FR, Campins M, Tammaro A, Rello J. Varicella-Zoster Virus Reactivation following Severe Acute Respiratory Syndrome Coronavirus 2 vaccination or infection: New Insights. European Journal of Internal Medicine 2022. [DOI: 10.1016/j.ejim.2022.07.022] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
6 Avallone G, Quaglino P, Cavallo F, Roccuzzo G, Ribero S, Zalaudek I, Conforti C. SARS-CoV-2 vaccine-related cutaneous manifestations: a systematic review. Int J Dermatol 2022. [PMID: 35141881 DOI: 10.1111/ijd.16063] [Cited by in Crossref: 11] [Cited by in F6Publishing: 15] [Article Influence: 11.0] [Reference Citation Analysis]
7 Shahrigharahkoshan S, Gagnon LP, Mathieu S. Cutaneous Leukocytoclastic Vasculitis Induction Following ChAdOx1 nCoV-19 Vaccine. Cureus 2021;13:e19005. [PMID: 34853744 DOI: 10.7759/cureus.19005] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
8 Desai HD, Sharma K, Shah A, Patoliya J, Patil A, Hooshanginezhad Z, Grabbe S, Goldust M. Can SARS-CoV-2 vaccine increase the risk of reactivation of Varicella zoster? A systematic review. J Cosmet Dermatol 2021;20:3350-61. [PMID: 34719084 DOI: 10.1111/jocd.14521] [Cited by in Crossref: 15] [Cited by in F6Publishing: 13] [Article Influence: 7.5] [Reference Citation Analysis]